Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Phosphorus or phosphorus compound
Patent
1996-06-27
1999-05-04
Pak, John
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Phosphorus or phosphorus compound
424601, 424605, 424606, 424 57, 423305, 423306, 423307, 423309, 606 76, 606 77, 623 16, 106690, 106691, A61K 3306, A61K 3342, C01B 2532, C01F 1102
Patent
active
059002549
ABSTRACT:
Carbonated hydroxyapatite compositions and their preparation are described. The compositions are biologically resorbable and are prepared as flowable masses which can be administered by syringe to set in situ to serve as a support structure, filler, prosthesis or the like. Optionally the compositions may include proteins or serve as a depot for compositions of phrarmacological interest.
REFERENCES:
patent: Re33161 (1990-02-01), Brown et al.
patent: Re33221 (1990-05-01), Brown et al.
patent: 3647371 (1972-03-01), Kim
patent: 3873327 (1975-03-01), Duff
patent: 3913229 (1975-10-01), Driskell
patent: 4048300 (1977-09-01), Tomlinson et al.
patent: 4097935 (1978-07-01), Jarcho
patent: 4139599 (1979-02-01), Tomlinson
patent: 4170658 (1979-10-01), Skinner
patent: 4279661 (1981-07-01), Strauch
patent: 4321042 (1982-03-01), Scheicher
patent: 4324772 (1982-04-01), Conn et al.
patent: 4335086 (1982-06-01), Spencer
patent: 4429691 (1984-02-01), Niwa
patent: 4481174 (1984-11-01), Iino
patent: 4518430 (1985-05-01), Brown et al.
patent: 4612053 (1986-09-01), Brown et al.
patent: 4917702 (1990-04-01), Scheicher
patent: 4959104 (1990-09-01), Iino
patent: 5092888 (1992-03-01), Iwamoto et al.
patent: 5149368 (1992-09-01), Liu
patent: 5152836 (1992-10-01), Hirano
patent: 5180426 (1993-01-01), Sumita
patent: 5262166 (1993-11-01), Liu et al.
patent: 5320844 (1994-06-01), Liu
patent: 5322675 (1994-06-01), Hakamatsu
patent: 5336264 (1994-08-01), Constantz et al.
patent: 5338356 (1994-08-01), Hirano et al.
patent: 5525148 (1996-06-01), Chow et al.
patent: 5536575 (1996-07-01), Imura et al.
patent: 5569490 (1996-10-01), Imura
patent: 5571493 (1996-11-01), Fulmer et al.
patent: 5580623 (1996-12-01), Fulmer et al.
patent: 5683496 (1997-11-01), Ison et al.
patent: 5709742 (1998-01-01), Fulmer et al.
patent: 5782971 (1998-07-01), Constantz et al.
Chohayeb et al., "Evaluation of calcium phosphate as a root canal sealer-filler material," J. Endodontics (Aug. 1987) 13: 384-387.
Laurence Chow, "Development of Self-Setting Calcium Phosphate Cements," J. Ceramic Soc. Japan (1991) 99: 954-964.
Friedman et al, "Hydroxyapatite Cement," Arch Otol. Head Neck Surg. (Apr. 1991) 117: 385-390.
Fukase et al., "Setting reactions and compressive strengths of calcium phosphate cements," J. Dental Res. (Dec. 1990) 69: 1852-1856.
Mirtchi et al., "Calcium phosphate cements: study of the B-tricalcium phosphate-monocalcium phosphate system," Biomaterials (Sep. 1989) 10: 475.
Mirtchi et al., "Calcium phosphate cements: study of the B-tricalcium phosphate-dicalcium phosphate-calcite cements," Biomaterials (Mar. 1990) 11: 84.
Roy et al., "Hydroxyapatite formed from coral skeletal carbonate by hydrothermal exchange," Nature (Jan. 25, 1974) 247:220-222.
Yu et al, "Self-setting hydroxyapatite cement: a novel skeletal drug delivery system for antibiotics," J. Pharmacuetical Science (Jun. 1992) 81: 529-531.
Mirtchi et al., Biomaterial (1991) 12:505-510.
Monma et al, Yogyo Kyokai-Shi (1984) 92:157.
Sanin, N. et al., "Effects of Additives on Setting Reaction of Calcium Phosphate Cement", AADR, Abstract No. 666 (Jan. 15, 1992).
Chow, S., "Calcium Phosphate Materials: Reactor Response," Adv. Dent. Res. (Aug. 1988) vol. 2:181-184.
Constantz, et al., "Pilot Investigations of A Calcium Phosphate Cement In A Rabbit Femoral Canal Model and A Canine Humeral Plug Model," 17th Annual Meeting of the Society for Biomaterials May 1-5 (1991).
Le Maitre, et al., "Calcium Phosphate Cements for Medical Use: State of the Art and Perspectives of Development," Silicate Industries (1987) vol. 9-10:141.
Monma et al., "Properties of Hydroxyapatite Prepared by Hydrolysis of Tricalcium Phosphate," J. Chem. Tech. Biotech. (1981) vol.31: 15-24.
Okazaki, et al., "Crystallinity, Solubility, and Dissolution Rate Behavior of Fluoridated CO .sub.3 Apatites," J. Biomedical Mat. Res. (1982) vol.16:851-860.
Nordstrom and Karlsson, "Carbonate-doped Hydroxyapatite," J. of Materials Science: Materials in Medicine (1990), 182-184.
Okazaki et al., "Solubility Behavior of CO.sub.3 Apatites in Relation to Crystallinity," Caries Research (1981), 15:477-483.
Doi et al., "Carbonate Apatites From Aqueous and Nonaqueous Media Studied by ESR, IR, and X-ray Diffraction: Effect of NH.sub.4 + Ions on Crystallographic Parameters," J. Dent. Res. (Feb. 1982), 61:429-434.
Hassan et al., "Mineralogical Studies on Bone Apatite and Their Implications for Radiocarbon Dating," Radiocarbon (1977), 19:364-374.
Chickerur and Mahapatra "Preparation of Arsenate and Carbonate Hydroxylapatites," J. Inst. Chemists (India) (May 1974), XLVI:57-58.
Vignoles et al., "Influence of Preparation Conditions on the Composition of Type B Carbonated Hydroxyapatite and on the Localization of the Carbonate Ions," Calcified Tissue International (1988), 43:33-40.
Nelson et al., "Effect of Carbonate and Fluoride on the Dissolution Behavior of Synthetic Apatites," Caries Res. (1983), 17:200-211.
Webster's Third New International Dictionary of the English Language Unabridged, G. & C. Marriam Co., MA, 1963, p. 893.
Field Bret
Norian Corporation
Pak John
LandOfFree
Carbonated hydroxyapatite compositions and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbonated hydroxyapatite compositions and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbonated hydroxyapatite compositions and uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1868668